Chargement en cours...
Semapimod sensitizes glioblastoma tumors to ionizing radiation by targeting microglia.
Glioblastoma is the most malignant and lethal form of astrocytoma, with patients having a median survival time of approximately 15 months with current therapeutic modalities. It is therefore important to identify novel therapeutics. There is mounting evidence that microglia (specialized brain-reside...
Enregistré dans:
| Auteurs principaux: | , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science (PLoS)
2014-01-01
|
| Collection: | PLoS ONE |
| Accès en ligne: | http://europepmc.org/articles/PMC4015930?pdf=render |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|